癫痫共病睡眠障碍脑网络机制研究

注册号:

Registration number:

ChiCTR2500099495 

最近更新日期:

Date of Last Refreshed on:

2025-03-25 09:26:37 

注册时间:

Date of Registration:

2025-03-25 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

癫痫共病睡眠障碍脑网络机制研究

Public title:

Research on the brain network mechanism of epilepsy comorbidity sleep disorders

注册题目简写:

English Acronym:

研究课题的正式科学名称:

癫痫共病睡眠障碍脑网络机制研究

Scientific title:

Research on the brain network mechanism of epilepsy comorbidity sleep disorders

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

黄超 

研究负责人:

刘凌 

Applicant:

Huang Chao  

Study leader:

Liu Ling 

申请注册联系人电话:

Applicant telephone:

+86 130 8660 0070

研究负责人电话:

Study leader's
telephone:

+86 139 8185 9029

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

494712879@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zjllxx@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省成都市武侯区人民南路三段16号

研究负责人通讯地址:

四川省成都市武侯区国学巷37号

Applicant address:

16 People's South Road, Section 3, Wuhou District, Chengdu City, Sichuan Province.

Study leader's address:

No. 37, Guoxue Lane, Wuhou District, Chengdu

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川大学华西医院

Applicant's institution:

West China Hospital, Sichuan University

研究负责人所在单位:

四川大学华西医院

Affiliation of the Leader:

West China Hospital, Sichuan University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025年审(147)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理审查委员会

Name of the ethic committee:

Biomedical Ethics Committee, West China Hospital, Sichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-02-19 00:00:00

伦理委员会联系人:

邓绍林

Contact Name of the ethic committee:

Deng Shaolin

伦理委员会联系地址:

四川省成都市武侯区国学巷37号八角亭2105

Contact Address of the ethic committee:

Octagonal Pavilion 2105, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 28 8542 2654

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学华西医院

Primary sponsor:

West China Hospital, Sichuan University

研究实施负责(组长)单位地址:

四川省成都市武侯区国学巷37号

Primary sponsor's address:

No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

成都市

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院

具体地址:

四川省成都市武侯区国学巷37号

Institution
hospital:

Department of Neurology, West China Hospital, Sichuan University

Address:

No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province

经费或物资来源:

四川大学研究生经费

Source(s) of funding:

Graduate Funding of Sichuan University

研究疾病:

癫痫共病睡眠障碍  

Target disease:

Epilepsy comorbid sleep disorders

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

1、揭示癫痫共病睡眠障碍产生的脑网络机制;2、揭示睡眠障碍影响癫痫疾病预后的脑网络机制。  

Objectives of Study:

1. To reveal the brain network mechanism of epilepsy comorbid sleep disorders; 2. Uncover the brain network mechanism of sleep disorders affecting the prognosis of epilepsy.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

癫痫共病睡眠障碍排除标准:(1)扫描前 3 个月无失眠及失眠药物服用史;(2)有认知功能损 害,存在明显的神经/精神 疾病(如脑瘫、失语症、精神分裂症等),无法准确完成调查问卷者;(3)临床资料不完整者;(4)不愿意参加本研究的癫痫共病睡眠障碍患者。

Exclusion criteria:

Epilepsy comorbid sleep disorder exclusion criteria: (1) no history of insomnia and insomnia medication in the 3 months prior to the scan; (2) Those who have cognitive impairment and obvious neurological/psychiatric diseases (such as cerebral palsy, aphasia, schizophrenia, etc.), and cannot accurately complete the questionnaire; (3) Incomplete clinical information; (4) Patients with epilepsy comorbid sleep disorders who are unwilling to participate in this study.

研究实施时间:

Study execute time:

From 2025-04-01 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-04-01 00:00:00 To 2026-05-31 00:00:00

干预措施:

Interventions:

组别:

单纯癫痫组

样本量:

60

Group:

Epilepsy alone

Sample size:

干预措施:

干预措施代码:

Intervention:

no

Intervention code:

组别:

睡眠障碍组

样本量:

60

Group:

Sleep disturbance group

Sample size:

干预措施:

干预措施代码:

Intervention:

no

Intervention code:

组别:

健康对照组

样本量:

60

Group:

Healthy control group

Sample size:

干预措施:

干预措施代码:

Intervention:

no

Intervention code:

组别:

癫痫共病睡眠障碍

样本量:

60

Group:

comorbid sleep disorders in epilepsy

Sample size:

干预措施:

干预措施代码:

Intervention:

no

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川省 

市(区县):

成都 

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院 

单位级别:

三甲 

Institution
hospital:

West China Hospital ,Sichuan University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川省 

市(区县):

成都 

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西第四医院 

单位级别:

三甲 

Institution
hospital:

West China Fourth Hospital of Sichuan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

聚类系数

指标类型:

主要指标

Outcome:

Clustering Coefficient

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

节点强度

指标类型:

主要指标

Outcome:

Node Strength

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

局部效率

指标类型:

主要指标

Outcome:

Local Efficiency

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

小世界

指标类型:

主要指标

Outcome:

Small-Worldness

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

全局效率

指标类型:

主要指标

Outcome:

Global Efficiency

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

模块化度

指标类型:

主要指标

Outcome:

Modularity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

连通性

指标类型:

主要指标

Outcome:

Connectivity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

参与系数

指标类型:

主要指标

Outcome:

participation coefficiency

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

模块内参与度

指标类型:

主要指标

Outcome:

within model degree

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

放电指数

指标类型:

次要指标

Outcome:

Discharge Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

放电部位

指标类型:

次要指标

Outcome:

Discharge Site

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

呼吸暂停-低通气指数

指标类型:

次要指标

Outcome:

Apnea-Hypopnea Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠效率

指标类型:

次要指标

Outcome:

Sleep Efficiency

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠潜伏期

指标类型:

次要指标

Outcome:

Sleep Latency

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

觉醒指数

指标类型:

次要指标

Outcome:

Awakening Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腿动指数

指标类型:

次要指标

Outcome:

Leg Movement Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数评分

指标类型:

附加指标

Outcome:

Pittsburgh Sleep Quality Index

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

爱泼斯坦睡眠评分

指标类型:

附加指标

Outcome:

Epworth Sleepiness Scale

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疲劳严重度评分

指标类型:

附加指标

Outcome:

Fatigue Severity Scale

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

NA

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2028年1月以后,与项目负责人联系获取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After January 2028, contact the project leader to obtain

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集:原始纸质采集表格 数据管理:上传四川大学研究生原始科研记录网站统一管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data Collection: Original paper collection form Data management: upload the original scientific research records of graduate students of Sichuan University for unified management

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-03-25 09:26:21